Børsen article can be read here for free

We are very happy to provide the opportunity to non-subscribers of Børsen to be able to read the article about Scandion Oncology for free.

The article is an interview with CEO Nils Brünner about the the development in Scandion Oncology and which directions are possible to achive the ultimate goal of bringing novel drugs to the market to fight anti-cancer drug resisance.

Artikel Børsen – Personligt tror jeg ikke vi får lov at være i fred